---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-044034"
form_type: "8-K"
ticker: "BJDX"
cik: "0001704287"
company_name: "Bluejay Diagnostics, Inc."
filed_at: "2024-05-16T23:59:59+00:00"
generated_at: "2026-06-01T21:27:34.131286+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Bluejay Diagnostics increases authorized shares from 7.5M to 50M; shareholders approve reverse stock split up to 1:10

## Summary
- Authorized shares of common stock increased from 7,500,000 to 50,000,000 via amendment filed May 14, 2024.
- Stockholders approved reverse stock split at ratio of 1-for-2 to 1-for-10; board to decide final ratio and timing.
- Directors Donald Chase, Neil Dey, Svetlana Dey, Fred Zeidman, Gary Gemignani, and Douglas Wurth re-elected.
- Ratification of Wolf & Company, P.C. as independent auditor for FY2024 approved.

## SEC filing metadata
- accession: 0001213900-24-044034
- form_type: 8-K
- ticker: BJDX
- cik: 0001704287
- company_name: Bluejay Diagnostics, Inc.
- filed_at: 2024-05-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1704287/000121390024044034/0001213900-24-044034-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1704287/000121390024044034/ea020636401-8k_bluejay.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-044034
- JSON: https://secwatch.observer/filing/0001213900-24-044034.json
- Plain text: https://secwatch.observer/filing/0001213900-24-044034.txt

## Source-grounded claims
- claim_id: 07b28d4d3cce60f812370222feb01670e74f8b33
  claim: Bluejay Diagnostics, Inc.: Increased authorized common shares from 7,500,000 to 50,000,000 via amendment to certificate of incorporation (effective 2024-05-14).
  evidence_excerpt: On May 14, 2024, Bluejay Diagnostics, Inc. (the “Company”) filed an amendment to its amended and restated certificate of incorporation, which amendment increased the number of authorized shares of the Company’s common stock from 7,500,000 to 50,000,000.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1704287/000121390024044034/0001213900-24-044034-index.htm
- claim_id: 2a04baf953ddd8812f00cb43b1360bbf9dcce743
  claim: Bluejay Diagnostics, Inc. shareholders approved Ratification of Wolf & Company, P.C. as the Company’s Independent Registered Public Accounting Firm at the 2024-05-14 meeting.
  evidence_excerpt: Proposal 4. Ratification of Wolf & Company, P.C. as the Company’s Independent Registered Public Accounting Firm - The Company’s stockholders ratified the appointment of Wolf & Company, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1704287/000121390024044034/0001213900-24-044034-index.htm
- claim_id: b90d72d3d85c39721516b04f2248c25156ca650f
  claim: Bluejay Diagnostics, Inc. shareholders approved Approval of an Amendment to the Company’s Certificate of Incorporation to Increase the Number of Authorized Shares of Common Stock at the 2024-05-14 meeting.
  evidence_excerpt: Proposal 2. Approval of an Amendment to the Company’s Certificate of Incorporation to Increase the Number of Authorized Shares of Common Stock - The Company’s stockholders approved and adopted an amendment to the Company’s certificate of incorporation to increase the number of authorized shares of the Company’s common stock.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1704287/000121390024044034/0001213900-24-044034-index.htm
- claim_id: c18b006103b1f92dbc41431f3c0124c43315061c
  claim: Bluejay Diagnostics, Inc. shareholders approved Approval of an Amendment to the Company’s Certificate of Incorporation to Effect a Reverse Stock Split at the 2024-05-14 meeting.
  evidence_excerpt: Proposal 3. Approval of an Amendment to the Company’s Certificate of Incorporation to Effect a Reverse Stock Split - The Company’s stockholders approved and adopted an amendment to the Company’s certificate of incorporation to effect a reverse stock split of all of the Company’s outstanding shares of common stock by one of several fixed ratios between 1-for-2 and 1-for-10 (the “Reverse Stock Split”), with the final decision of whether to proceed with the Reverse Stock Split, the effective time of the Reverse Stock Split, and the exact ratio of the Reverse Stock Split to be determined in the future by the Company’s board of directors, in its sole discretion and without further action by the Company’s stockholders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1704287/000121390024044034/0001213900-24-044034-index.htm
- claim_id: c5dfd89f6b5f13d00f02616168e0ef685a765547
  claim: Bluejay Diagnostics, Inc. shareholders approved Election of directors at the 2024-05-14 meeting.
  evidence_excerpt: Proposal 1. Election of Directors - The Company’s stockholders re-elected each of Donald Chase, Neil Dey, Svetlana Dey, Fred Zeidman, Gary Gemignani and Douglas Wurth to serve as directors until the 2025 Annual Meeting of Stockholders, or until their successors are duly elected and qualified.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1704287/000121390024044034/0001213900-24-044034-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.